Bristol-Myers Squibb, uniQure to Develop Gene Therapies
The collaboration includes uniQure’s proprietary gene therapy program for congestive heart failure that is intended to restore the heart’s ability to synthesize S100A1
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Congestive Heart Failure | Gene Therapy | Genetics | Heart | Heart Failure | Pharmaceuticals